Erectile dysfunction medications turn men’s vision blue

Spread the love

In case people are a man who has experienced the to some degree humiliating procedure of conversing with people’s lack of performance in the bedroom, they would trust that requesting help is the greatest obstacle they need to overcome. For a few, be that as it may, getting a prescription for Viagra or its generic form, sildenafil, is only the start of a new set of issues.

In a new research article published in Frontiers in Neurology, the cases of 17 men are depicted. The men were viewed as overall healthy however had encountered issues with erectile dysfunction and were offered sildenafil to help.

In these 17 cases, the men encountered a wide range of vision issues that aren’t typical with patients taking the medication. These “visual disturbances” included everything from sensitivity to light to “disrupted color perception” in which their vision took on an overall bluish hue. Different symptoms included dilated students, absence of focus, and contrast sensitivity.

These sorts of side effects are not unbelievable, yet the seriousness with which some of these men encountered the impacts was cause for concern. Specifically, the “blue vision” impact has been noted to last for a short while in certain men, yet these cases included patients who revealed, “very intensely blue-colored vision with red-green color blindness” that persevered for at least an entire day, which is far longer than anticipated.

The good news is that in the cases of all 17 men, the “ocular side effects spontaneously resolved,” as indicated by the report. The specialists recommend that the discoveries point to a requirement for doctors to begin patients off on extremely low doses of sildenafil to screen for side effects before ramping up the dosage as needed.

“These findings support the practice of starting patients on a modest dose of sildenafil for ED and other indications. Also, these findings further support the notion that a 100-mg dose of sildenafil should be reserved for patients who did not obtain satisfactory results with a 50-mg trial dose and did not experience heightened sensitivity to the drug as a result of the trial dose.”

All things considered, no one wants to be stuck seeing blue.

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No News View 360 journalist was involved in the writing and production of this article.